DFT Studies and Acetylcholinesterase Inhibition Capacity Analysis of an Adamantane-Isothiourea Derivative via Docking and MD Calculations

References

• A. Štimac, M. Šekutor, K. Mlinarić-Majerski, L. Frkanec, and R. Frkanec, “Adamantane in Drug Delivery Systems and Surface Recognition,” Molecules 22, no. 2 (2017): 297. doi:10.3390/molecules22020297
   PubMed Web of Science ®Google Scholar
• H. Schwertfeger, A.A. Fokin, and P.R. Schreiner, “Diamonds Are a Chemist’s Best Friend. Diamondoid Chemistry beyond Adamantane,” Angewandte Chemie (International Ed. in English) 47, no. 6 (2008): 1022–36. doi:10.1002/anie.200701684
   PubMed Web of Science ®Google Scholar
• M.A. Unawan, J.-C. Hierso, D. Poinsot, A.A. Fokin, N.A. Fokina, B.A. Tkachenko, and P.R. Schreiner, “Diamondoids: Functionalization and Subsequent Applications of Perfectly Defined Molecular Cage Hydrocarbons,” New Journal of Chemistry 38, no. 1 (2014): 28–41. doi:10.1039/C3NJ00535F
   Web of Science ®Google Scholar
• H. Gökce, Y. Sert, N. Öztürk, A. A.-M. Abdel-Aziz, A.S. El-Azab, and A.M. Al-Obaid, “Experimental and Theoretical Investigations on Structural, Spectroscopic, Electronic and Thermodynamic Properties of (Adamantan-1-Yl)(Phenylsulfanyl)Methanone,” Journal of Molecular Structure 1173 (2018): 596–607. doi:10.1016/j.molstruc.2018.07.031
   Web of Science ®Google Scholar
• S. Landa, and V. Macháček, “Sur L’adamantane, Nouvel Hydrocarbure Extrait Du Naphte,” Collection of Czechoslovak Chemical Communications 5 (1933): 1–5. doi:10.1135/cccc19330001
   Google Scholar
• V. Prelog, and R. Seiwerth, “Über Die Synthese Des Adamantans,” Berichte Der Deutschen Chemischen Gesellschaft (A and B Series) 74, no. 10 (1941): 1644–8. doi:10.1002/cber.19410741004
   Google Scholar
• G.E. Henry, H. Jacobs, C.M.S. Carrington, S. McLean, and W.F. Reynolds, “Plukenetione A. An Unusual Adamantyl Ketone from Clusia Plukenetii (Guttiferae),” Tetrahedron Letters 37, no. 48 (1996): 8663–6. doi:10.1016/S0040-4039(96)02004-7
   Web of Science ®Google Scholar
• D. Díaz-Carballo, S. Malak, W. Bardenheuer, M. Freistuehler, and H.P. Reusch, “The Contribution of Plukenetione a to the anti-Tumoral Activity of Cuban Propolis,” Bioorganic & Medicinal Chemistry 16, no. 22 (2008): 9635–43. doi:10.1016/j.bmc.2008.10.019
   PubMed Web of Science ®Google Scholar
• W.L. Davies, R.R. Grunert, R.F. Haff, J.W. Mcgahen, E.M. Neumayer, M. Paulshock, J.C. Watts, T.R. Wood, E.C. Hermann, and C.E. Hoffmann, “Antiviral Activity of 1-Adamantamine Amantadine,” Science (New York, NY) 144, no. 3620 (1964): 862–3. doi:10.1126/science.144.3620.862
   Google Scholar
• S. Rabinovich, J.T. Baldini, and R. Bannister, “Treatment of Influenza. The Therapeutic Efficacy of Rimantadine HCl in a Naturally Occurring Influenza A2 Outbreak,” The American Journal of the Medical Sciences 257, no. 5 (1969): 328–35. doi:10.1097/00000441-196905000-00005
   PubMed Web of Science ®Google Scholar
• W.L. Wingfield, D. Pollack, and R.R. Grunert, “Treatment of Influenza,” The New England Journal of Medicine 281, no. 11 (1969): 579–84. doi:10.1056/NEJM196909112811102
   PubMed Web of Science ®Google Scholar
• K.S. Rosenthal, M.S. Sokol, R.L. Ingram, R. Subramanian, and R.C. Fort, “Tromantadine: Inhibitor of Early and Late Events in Herpes Simplex Virus Replication,” Antimicrobial Agents and Chemotherapy 22, no. 6 (1982): 1031–6. doi:10.1128/AAC.22.6.1031
   PubMed Web of Science ®Google Scholar
• S.M. Iu, V.A. Shibnev, I.T. Finogenova, T.M. Fediakina, T.M. Garaev, N.V. Markova, and I.M. Kirillov, “The Antiviral Activity of the Adamantane Derivatives against the Influenza Virus A (H1N1) pdm2009 Model in Vivo, Vopr,” Virusol 59 (2014): 37–40.
   Google Scholar
• V.A. Shibnev, T.M. Garaev, M.P. Finogenova, E.S. Shevchenko, and E.I. Burtseva, “New Adamantane Derivatives Can Overcome Resistance of Influenza A(H1N1)pdm2009 and A(H3N2) Viruses to Remantadine,” Bulletin of Experimental Biology and Medicine 153, no. 2 (2012): 233–5. doi:10.1007/s10517-012-1684-x
   PubMed Web of Science ®Google Scholar
• J. Balzarini, B. Orzeszko-Krzesińska, J.K. Maurin, and A. Orzeszko, “Synthesis and anti-HIV Studies of 2- and 3-Adamantyl-Substituted Thiazolidin-4-Ones,” European Journal of Medicinal Chemistry 44, no. 1 (2009): 303–11. doi:10.1016/j.ejmech.2008.02.039
   PubMed Web of Science ®Google Scholar
• A.A. El-Emam, O.A. Al-Deeb, M. Al-Omar, and J. Lehmann, “Synthesis, Antimicrobial, and anti-HIV-1 Activity of Certain 5-(1-Adamantyl)-2-Substituted Thio-1,3,4-Oxadiazoles and 5-(1-Adamantyl)-3-Substituted Aminomethyl-1,3,4-Oxadiazoline-2-Thiones,” Bioorganic & Medicinal Chemistry 12, no. 19 (2004): 5107–13. doi:10.1016/j.bmc.2004.07.033
   PubMed Web of Science ®Google Scholar
• M.E. Burstein, A.V. Serbin, T.V. Khakhulina, I.V. Alymova, L.L. Stotskaya, O.P. Bogdan, E.E. Manukchina, V.V. Jdanov, N.K. Sharova, and A.G. Bukrinskaya, “Inhibition of HIV-1 Replication by Newly Developed Adamantane-Containing Polyanionic Agents,” Antiviral Research 41, no. 3 (1999): 135–44. doi:10.1016/s0166-3542(99)00006-6
   PubMed Web of Science ®Google Scholar
• L. Jia, J.E. Tomaszewski, C. Hanrahan, L. Coward, P. Noker, G. Gorman, B. Nikonenko, and M. Protopopova, “Pharmacodynamics and Pharmacokinetics of SQ109, a New Diamine-Based Antitubercular Drug,” British Journal of Pharmacology 144, no. 1 (2005): 80–7. doi:10.1038/sj.bjp.0705984
   PubMed Web of Science ®Google Scholar
• A. Ragab, M.S. Abusaif, D.S. Aboul-Magd, M.M.S. Wassel, G.A.M. Elhagali, and Y.A. Ammar, “A New Exploration toward Adamantane Derivatives as Potential anti-MDR Agents: Design, Synthesis, Antimicrobial, and Radiosterilization Activity as Potential Topoisomerase IV and DNA Gyrase Inhibitors,” Drug Development Research 83, (2022): 1305–30.
   PubMed Web of Science ®Google Scholar
• P. Lorenzo, R. Alvarez, M.A. Ortiz, S. Alvarez, F.J. Piedrafita, and A.R. de Lera, “Inhibition of IκB Kinase-β and Anticancer Activities of Novel Chalcone Adamantyl Arotinoids,” Journal of Medicinal Chemistry 51, no. 17 (2008): 5431–40. doi:10.1021/jm800285f
   PubMed Web of Science ®Google Scholar
• T. Han, M. Goralski, E. Capota, S.B. Padrick, J. Kim, Y. Xie, and D. Nijhawan, “The Antitumor Toxin CD437 is a Direct Inhibitor of DNA Polymerase α,” Nature Chemical Biology 12, no. 7 (2016): 511–5. doi:10.1038/nchembio.2082
   PubMed Web of Science ®Google Scholar
• L.H. Al-Wahaibi, H.M. Hassan, A.M. Abo-Kamar, H.A. Ghabbour, and A.A. El-Emam, “Adamantane-Isothiourea Hybrid Derivatives: Synthesis, Characterization, in Vitro Antimicrobial, and in Vivo Hypoglycemic Activities,” Molecules 22, no. 5 (2017): 710. doi:10.3390/molecules22050710
   PubMed Web of Science ®Google Scholar
• S. Yusuf, L.H. Al-Wahaibi, H. Gökce, H.M. Hassan, A. Aisha, and A.A. El-Emam, “Molecular Docking, Hirshfeld Surface Analysis and Spectroscopic Investigations of 1-(Adamantan-1-Yl)-3-(4-Fluorophenyl)Thiourea: A Potential Bioactive Agent,” Chemical Physics Letters. 735 (2019): 136762. doi:10.1016/j.cplett.2019.136762
   Web of Science ®Google Scholar
• H.M. Hassan, L.H. Al-Wahaibi, G.S. Shehatou, and A.A. El-Emam, “Adamantane-Linked Isothiourea Derivatives Suppress the Growth of Experimental Hepatocellular Carcinoma via Inhibition of TLR4-MyD88-NF-κB Signaling,” American Journal of Cancer Research 11, no. 2 (2021): 350–69. PMID: 33575076
   PubMed Web of Science ®Google Scholar
• H.C. Kwong, S.H. Mah, T.S. Chia, C.K. Quah, G.K. Lim, and C.S.C. Kumar, “Cholinesterase Inhibitory Activities of Adamantyl-Based Derivatives and Their Molecular Docking Studies,” Molecules 22, no. 6 (2017): 1005. doi:10.3390/molecules22061005
   PubMed Web of Science ®Google Scholar
• P.T. Francis, A.M. Palmer, M. Snape, and G.K. Wilcock, “The Cholinergic Hypothesis of Alzheimer’s Disease: A Review of Progress,” Journal of Neurology, Neurosurgery, and Psychiatry 66, no. 2 (1999): 137–47. doi:10.1136/jnnp.66.2.137
   PubMed Web of Science ®Google Scholar
• M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, G. Scalmani, V. Barone, G.A. Petersson, H. Nakatsuji, et al., Gaussian 09, Revision E01 (Wallingford CT: Gaussian, Inc., 2016).
   Google Scholar
• R. Parr, and G. Pearson, “Absolute Hardness: Companion Parameter to Absolute Electronegativity,” Journal of the American Chemical Society 105, no. 26 (1983): 7512–6. doi:10.1021/ja00364a005
   Web of Science ®Google Scholar
• R. Parr, L. Szentpaly, and S. Liu, “Electrophilicity Index,” Journal of the American Chemical Society 121, no. 9 (1999): 1922–4. doi:10.1021/ja983494x
   Web of Science ®Google Scholar
• R.G. Parr, and Y. Weitao, Density-Functional Theory of Atoms and Molecules (Oxford: Oxford University Press, 1994).
   Google Scholar
• P.B. Kole, S.P. Kollur, H.D. Revanasiddappa, C. Shivamallu, R.A. Costa, E.S.A. Junior, L.M. Anselmo, J.N. da Silva, C. Srinivasa, A. Syed, et al, “Structural, Electronic, Vibrational and Pharmacological Investigations of Highly Functionalized Diarylmethane Molecules Using DFT Calculations, Molecular Dynamics and Molecular Docking,” Polycyclic Aromatic Compounds 43, no. 3 (2022): 2177–2195. doi:10.1080/10406638.2022.2041050
   Web of Science ®Google Scholar
• J.S. Al-Otaibi, R.A. Costa, E.V. Costa, V.L. Tananta, Y.S. Mary, and Y.S. Mary, “Insights into Solvation, Chemical Reactivity, Structural, Vibrational and anti-Hypertensive Properties of a Thiazolopyrimidine Derivative by DFT and MD Simulations,” Structural Chemistry 33, no. 4 (2022): 1271–83. doi:10.1007/s11224-022-01931-1
   Web of Science ®Google Scholar
• J.L. Gazquez, A. Cedillo, and A. Vela, “Electrodonating and Electroaccepting Powers,” The Journal of Physical Chemistry A 111, no. 10 (2007): 1966–70. doi:10.1021/jp065459f
   PubMed Web of Science ®Google Scholar
• J.M.L. Martin, and C. Van Alsenoy, GAR2PED, A Program to Obtain a Potential Energy Distribution Froma Gaussian Archive Record (Antwerpen, Belgium: University of Antwerp Belgium, 2007).
   Google Scholar
• A.V. Marenich, C.J. Cramer, and D.G. Truhlar, “Universal Solvation Model Based on Solute Electron Density and on a Continuum Model of the Solvent Defined by the Bulk Dielectric Constant and Atomic Surface Tensions,” The Journal of Physical Chemistry B 113, no. 18 (2009): 6378–96. doi:10.1021/jp810292n
   PubMed Web of Science ®Google Scholar
• O. Trott, and A.J. Olson, “AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efcient Optimization,” Journal of Computational Chemistry 31 (2010): 455–61.
   PubMed Web of Science ®Google Scholar
• J.A. Lemkul, W.J. Allen, and D.R. Bevan, “Practical Consideration for Building GROMOS-Compatible Small Molecule Topologies,” Journal of Chemical Information and Modeling 50, no. 12 (2010): 2221–35. doi:10.1021/ci100335w
   PubMed Web of Science ®Google Scholar
• R. Kumari, R. Kumar, and A. Lynn, “Open Source Drug Discovery Consortium: A.Lynn, g-Mmpbsa-a GROMACS Tool for High Throughput MM-PBSA Calculations,” Journal of Chemical Information and Modeling 54, no. 7 (2014): 1951–62. doi:10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• L.H. Al-Wahaibi, H.M. Hassan, A.M. Abo-Kamar, H.A. Ghabbour, and A.A. El-Emam, “Crystal Structure of 4-Bromobenzyl (Z)-N′-(Adamantan-1-Yl)-4-Phenylpiperazine-1-Carbothioimidate, C28H34BrN3S,” Zeitschrift Für Kristallographie - New Crystal Structures 232, no. 2 (2017): 189–91. doi:10.1515/ncrs-2016-0184
   Web of Science ®Google Scholar
• R.A. Costa, E.S.A. Junior, J.A. Bezerra, J.M. Mar, E.S. Lima, M.L.B. Pinheiro, D.V.C. Mendonça, G.B.P. Lopes, A.D.S. Branches, and K.M.T. Oliveira, “Theoretical Investigation of the Structural, Spectroscopic, Electronic, and Pharmacological Properties of 4-Nerolidylcathecol, an Important Bioactive Molecule,” Journal of Chemistry 2019 (2019): 1–14. doi:10.1155/2019/9627404
   Web of Science ®Google Scholar
• R.A. Costa, J.N. Silva, K.M.T. Oliveira, L.M. Dutra, and E.V. Costa, “Quantum Chemical Studies, Vibrational Analysis, Molecular Dynamics and Docking Calculations of Some Ent-Kaurane Diterpenes from Annona Vepretorum: A Theoretical Approach to Promising anti-Tumor Molecules,” Structural Chemistry 31, no. 3 (2020): 1223–43. doi:10.1007/s11224-020-01491-2
   Web of Science ®Google Scholar
• Y.Z. Zheng, G. Deng, Q. Liang, D.F. Chen, R. Guo, and R.C. Lai, “Antioxidant Activity of Quercetin and Its Glucosides from Propolis: A Theoretical Study,” Scientific Reports 7, no. 1 (2017): 7543. doi:10.1038/s41598-017-08024-8
   PubMed Web of Science ®Google Scholar
• R.A. Costa, J.N. Silva, V.G. Oliveira, L.M. Anselmo, M.M. Araújo, K.M.T. Oliveira, and R.C.S. Nunomura, “New Insights into Structural, Electronic, Reactivity, Spectroscopic and Pharmacological Properties of Bergenin: Experimental, DFT Calculations, MD and Docking Simulations,” Journal of Molecular Liquids 330 (2021): 115625. doi:10.1016/j.molliq.2021.115625
   Web of Science ®Google Scholar
• P. Sjoberg, and P. Politzer, “Use of the Electrostatic Potential at the Molecular Surface to Interpret and Predict Nucleophilic Processes,” The Journal of Physical Chemistry 94, no. 10 (1990): 3959–61. doi:10.1021/j100373a017
   Web of Science ®Google Scholar
• M. Orozco, and F.J. Luque, “Generalization of the Molecular Electrostatic Potential for the Study of Noncovalent Interactions,” Journal of Computational Biophysics and Chemistry 3 (1996): 181–218.
   Google Scholar
• P. Politzer, J.S. Murray, and F.A. Bulat, “Average Local Ionization Energy: A Review,” Journal of Molecular Modeling 16, no. 11 (2010): 1731–42. doi:10.1007/s00894-010-0709-5
   PubMed Web of Science ®Google Scholar
• C.S. Abraham, S. Muthu, J.C. Prasana, S. Armaković, S.J. Armaković, B. Fathima Rizwana, B. Geoffrey, and R.H.A. David, “Computational Evaluation of the Reactivity and Pharmaceutical Potential of an Organic Amine: A DFT, Molecular Dynamics Simulations and Molecular Docking Approach,” Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy 222 (2019): 117188. doi:10.1016/j.saa.2019.117188
   PubMed Web of Science ®Google Scholar
• R.G. Parr, and W. Yang, “Density Functional Approach to the Frontier-Electron Theory of Chemical Reactivity,” Journal of the American Chemical Society 106, no. 14 (1984): 4049–50. doi:10.1021/ja00326a036
   Web of Science ®Google Scholar
• P.W. Ayers, and R.G. Parr, “Variational Principles for Describing Chemical Reactions: The Fukui Function and Chemical Hardness Revisited,” Journal of the American Chemical Society 122, no. 9 (2000): 2010–8. doi:10.1021/ja9924039
   Web of Science ®Google Scholar
• M.H. Rahuman, S. Muthu, B.R. Raajaraman, M. Raja, and H. Umamahesvari, “Investigations on 2-(4-Cyanophenylamino) Acetic Acid by FT-IR,FT-Raman, NMR and UV-Vis Spectroscopy, DFT (NBO, HOMO-LUMO, MEP and Fukui Function) and Molecular Docking Studies,” Heliyon 6, no. 9 (2020): E04976. doi:10.1016/j.heliyon.2020.e04976
   PubMed Web of Science ®Google Scholar
• C. Morell, A. Grand, and A. Toro-Labbe, “New Dual Descriptor for Chemical Reactivity,” The Journal of Physical Chemistry A 109, no. 1 (2005): 205–12. doi:10.1021/jp046577a
   PubMed Web of Science ®Google Scholar
• J.I. Martínez-Araya, “Why is the Dual Descriptor a More Accurate Local Reactivity Descriptor than Fukui Functions?,” Journal of Mathematical Chemistry 53, no. 2 (2015): 451–65. doi:10.1007/s10910-014-0437-7
   Web of Science ®Google Scholar
• C.J. Morris, and D.D. Corte, “Using Molecular Docking and Molecular Dynamics to Investigate Protein-Ligand Interactions,” Modern Physics Letters B 35, no. 08 (2021): 2130002. doi:10.1142/S0217984921300027
   Google Scholar
• L.H.S. Santos, R.S. Ferreira, and E.R. Caffarena, “Integrating Molecular Docking and Molecular Dynamics Simulations,” in Docking Screens for Drug Discovery. Methods in Molecular Biology, edited by De Azevedo Jr., W., vol 2053. (New York, NY: Humana, 2019).
   Google Scholar
• M.M. Hammouda, A.A. Elmaaty, M.S. Nafie, M. Abdel-Motaal, N.S. Mohamed, M.A. Tantawy, A. Belal, R. Alnajjar, W.M. Eldehna, and A.A. Al‐Karmalawy, “Design and Synthesis of Novel Benzoazoninone Derivatives as Potential CBSIs and Apoptotic Inducers: In Vitro, In Vivo, Molecular Docking, Molecular Dynamics, and SAR Studies,” Bioorganic Chemistry 127 (2022): 105995. doi:10.1016/j.bioorg.2022.105995
   PubMed Web of Science ®Google Scholar
• A.A. Zaki, A. Ashour, S.S. Elhady, K.M. Darwish, and A.A. Al-Karmalawy, “Calendulaglycoside A Showing Potential Activity against SARS-CoV-2 Main Protease: Molecular Docking, Molecular Dynamics, and SAR Studies,” Journal of Traditional and Complementary Medicine 12, no. 1 (2022): 16–34. doi:10.1016/j.jtcme.2021.05.001
   PubMedGoogle Scholar
• R. Singh, V.K. Bhardwaj, J. Sharma, R. Purohit, and S. Kumar, “In-Silico Evaluation of Bioactive Compounds from Tea as Potential SARS-CoV-2 Nonstructural Protein 16 Inhibitors,” Journal of Traditional and Complementary Medicine 12, no. 1 (2022): 35–43. doi:10.1016/j.jtcme.2021.05.005
   PubMedGoogle Scholar
• J.W. Pitera, “Expected Distributions of Root-Mean-Square Positional Deviations in Proteins,” The Journal of Physical Chemistry B 118, no. 24 (2014): 6526–30. doi:10.1021/jp412776d
   PubMed Web of Science ®Google Scholar
• M.Y. Lobanov, N.S. Bogatyreva, and O.V. Galzitskaya, “Radius of Gyration as an Indicator of Protein Structure Compactness,” Molecular Biology 42, no. 4 (2008): 623–8. doi:10.1134/S0026893308040195
   Web of Science ®Google Scholar